Obsidian Therapeutics, Inc. Common Stock (OBX) is a publicly traded the market company. As of November 6, 2026, OBX trades at $11.69 with a market cap of $678.88M and a P/E ratio of 0.00. OBX moved +20.52% today. Year to date, OBX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $9.79 to $49.97. Analyst consensus is strong buy with an average price target of $40.00. Rallies surfaces OBX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OBX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OBX recently traded at $11.69. Market cap is $678.88M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $11.69 |
| Market Cap | $678.88M |
| P/E Ratio |
| 0.00 |
| EPS | $0.00 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $49.97 |
|---|
| 52-Week Low | $9.79 |
|---|
| Volume | 134.30K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $0 |
|---|
| Gross Margin | 0.00% |
|---|
5 analysts cover OBX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.00.